Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.
Sponsor: Instituto de Investigación Sanitaria Aragón
Summary
Dietary intervention with eicosapentaenoic acid combined with chemotherapy may shift inflammatory mediators toward resolution in non-resectable hepatocarcinoma and help to preserve muscle mass.
Official title: Effects of Nutritional Supplementation With Eicosapentaenoic Acid (EPA) on Body Composition and Systemic Pro-inflammatory and Pro-resolving Mediators in Patients Diagnosed With Unresectable Hepatocellular Carcinoma.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2019-03-04
Completion Date
2025-06-20
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
Eicosapentaenoic acid oral lipidic emulsion
1 sachet/day of 20 ml containing 3g EPA during 12 weeks
Pacebo oral lipidic emulsion
1 sachet/day of 20 ml of placebo during 12 weeks
Locations (1)
Hospital Clínico Universitario Lozano Blesa. IIS Aragón
Zaragoza, Zaragoza, Spain